reach
top tier result church demonstr compani continu abil
deliv top tier result core busi supplement futur
growth deal posit long-term despit weak specialti
biz organ revenue compani maintain guidanc core
busi evid oper flexibl stay neutral rate due
report organ revenu led household
benefit better price share gain categori laundri
litter continu momentum overseascanada germani china
slowdown condom waterpik busi weak specialti due
challeng dairi industri modest offset ebit margin expand
y/i behind price increas volum leverag product gain
partial off-set higher commod manufactur cost
remain neutral due rich valuat ep guid maintain
y/i due one-tim cost flawless acquisit
church base busi outlook improv due higher price volum
modestli lower commod cost impli earn growth
high-end guidanc rang underscor firm divers portfolio
strong brand equiti exposur growth categori church
grow organ top-line yet trade forward earn average
in-lin hsd top-line grower like monster bev este lauder
estim valuat rais ep estim
light quarter beat also rais target multipl due improv
base busi outlook new price target prior base
ep estim prior discount
risk increas competit activ us household poor execut
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
church dwight inc produc market arm
hammer trojan first respons larg portfolio household
product brand busi organ two segment
consum domest consum intern
price may rate neutral target price analyst kaumil gajrawala
profit tax
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
share could trade high end chd
averag ntm price-to-earnings multipl suggest sky price
scenario assum top line acceler base
combin sustain organ growth plu addit
contribut would expect ebit margin expand
share could contract weak perform low
end chd averag ntm price-to-earnings multipl suggest
grey sky price assum top-line deceler
base weak organ growth plu revenu boost
recent acquisit would expect ebit margin contract
lack oper leverag ebit margin could fall
 close
compani mention price
